...
【24h】

Reply

机译:回复

获取原文
获取原文并翻译 | 示例

摘要

Zhang and Zhang offered some comments regarding our study. First, they mentioned that the epithelial-on technique halts the progression of ectasia cases and cited the work of Filippello et al. However, the study by Filippello et al has a major limitation similar to ours, which is 1-year follow-up. Therefore, the results of the mentioned reference cannot be adopted as an absolute fact, as further studies with larger numbers of patients followed for longer periods are needed. Second, other studies regarding transepithelial cross-linking (CXL) have shown that this procedure had a limited effect in comparison with traditional CXL, and per Caporos-si et al, "according to limited penetration, its mid- to long-term efficacy needs to be determined in different clinical settings related to patient age and keratoconus progression."
机译:张和张就我们的研究发表了一些评论。首先,他们提到上皮技术阻止了扩张期病例的进展,并引用了Filippello等人的工作。但是,Filippello等人的研究有一个与我们类似的主要局限性,即为期1年的随访。因此,不能将上述参考文献的结果作为绝对事实,因为需要对更多患者进行更长时间的进一步研究。其次,有关跨上皮交联(CXL)的其他研究表明,与传统CXL相比,该方法的作用有限,并且根据Caporos-si等人的观点,“由于渗透率有限,因此需要中长期疗效在与患者年龄和圆锥角膜进展有关的不同临床环境中确定。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号